연구동향 분석

Charlson Comorbidity Index Is an Important Prognostic Factor for Long-Term Survival Outcomes in Korean Men with Prostate Cancer after Radical Prostatectomy

이주용 조강수 이대훈 조남훈 나군호 최영득 홍성준 양승철 2014년

논문상세정보
인용/피인용
' Charlson Comorbidity Index Is an Important Prognostic Factor for Long-Term Survival Outcomes in Korean Men with Prostate Cancer after Radical Prostatectomy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • comorbidity
  • prostatic neoplasms
  • survival
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,908 0

0.0%

' Charlson Comorbidity Index Is an Important Prognostic Factor for Long-Term Survival Outcomes in Korean Men with Prostate Cancer after Radical Prostatectomy' 의 참고문헌

  • Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?
    Froehner M BJU Int 110 206-210 [2012]
  • The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population-based study
    Post PN BJU Int 87 821-826 [2001]
  • The assessment of patient life-expectancy: how accurate are urologists and oncologists?
    Wilson JR BJU Int 95 794-798 [2005]
  • The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    von Elm E Prev Med 45 247-251 [2007]
  • Survival model predictive accuracy and ROC curves
    Heagerty PJ Biometrics 61 92-105 [2005]
  • Recent Changes in the Clinicopathologic Features of Korean Men with Prostate Cancer: A Comparison with Western Populations
    변석수 Yonsei Medical Journal 53 3 543-549 [2012]
  • Quality of life and satisfaction with outcome among prostate-cancer survivors
    Sanda MG N Engl J Med 358 1250-1261 [2008]
  • Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines
    Mohler JL J Natl Compr Canc Netw 10 1081-1087 [2012]
  • Prostate Cancer and Sexual Function
    현재석 The World Journal of Men's Health 30 2 99-107 [2012]
  • Prognostic value of Her-2/neu and clinicopathologic factors for evaluating progression and disease-specific death in Chinese men with prostate cancer
    Zhang YF Chin Med J (Engl) 124 4345-4349 [2011]
  • Prevalence and severity of morbidity among Gujarati Asian elders: a controlled comparison
    Ebrahim S Fam Pract 8 57-62 [1991]
  • Prediction of mortality after radical prostatectomy by Charlson comorbidity index
    Guzzo TJ Urology 76 553-557 [2010]
  • Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy
    Tewari A Eur Urol 62 1-15 [2012]
  • Morbidity and related factors among elderly people in South Korea: results from the Ansan Geriatric (AGE) cohort study
    Woo EK BMC Public Health 7 10- [2007]
  • Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study
    Lund L Urology 72 1258-1262 [2008]
  • Impact of comorbidity on survival among men with localized prostate cancer
    Albertsen PC J Clin Oncol 29 1335-1341 [2011]
  • Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis
    Briganti A Eur Urol 63 693-701 [2013]
  • Health, life expectancy, and mortality patterns among immigrant populations in the United States
    Singh GK Can J Public Health 95 114-121 [2004]
  • Greenfield S, et al. Comorbidity and competing risks for mortality in men with prostate cancer
    Daskivich TJ Cancer 117 4642-4650 [2011]
  • Global cancer statistics, 2002
    Parkin DM CA Cancer J Clin 55 74-108 [2005]
  • Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy
    Froehner M Eur Urol 47 190-195 [2005]
  • External validation of the cancer of the prostate risk assessment score to predict biochemical relapse after radical prostatectomy for prostate cancer in Japanese patients
    Yoshida T Urol Int 89 45-51 [2012]
  • Elevated Insulin and Insulin Resistance Are Associated with the Advanced Pathological Stage of Prostate Cancer in Korean Population
    윤석중 Journal of Korean Medical Science 27 9 1079-1084 [2012]
  • Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics
    Schröder FH Eur Urol 53 468-477 [2008]
  • EAU guidelines on prostate cancer
    Heidenreich A Eur Urol 53 68-80 [2008]
  • Development and validation of comorbidity index in South Korea
    Kil SR INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE 24 4 391-402 [2012]
  • Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy
    Froehner M Urology 72 1252-1257 [2008]
  • Correlations between age, Charlson score and outcome in clinical unilateral T3a prostate cancer
    Hsu CY Asian J Androl 11 131-137 [2009]
  • Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age
    Froehner M Urology 68 583-586 [2006]
  • Community-based prostate cancer screening in Japan: predicting factors for positive repeat biopsy
    Okada K Int J Urol 17 541-547 [2010]
  • Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys
    Lim S Diabetes Care 28 1810-1812 [2005]
  • Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
    노윤관 Korean Journal of Urology 53 12 826-829 [2012]
  • Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives
    Romano PS J Clin Epidemiol 46 1075-1079 [1993]
  • 20-year outcomes following conservative management of clinically localized prostate cancer
    Albertsen PC JAMA 293 2095-2101 [2005]